Board of Directors

David Borland – Chair

David is a high-tech leader, having built and led organizations at Intel, co-founded Calxeda, and started the semiconductor and machine learning acceleration teams at Amazon Web Services. As he winds down his focus on high-tech, David is Executive Director and Board Chair for Crossmen Productions, a youth development and performing arts non-profit, an active musician, and an arts education advocate. David’s wife is impacted by CCM2 mutation and has had three significant bleeds over the last 30 years. David is excited to be part of the effort to find a cure.

Dorothy Robinson – vice chair

Dorothy Robinson is an attorney who has spent her legal career in the higher education and nonprofit world, including serving as Yale University’s general counsel for some 30 years. She was in private practice before her time at Yale and now in her “quasi-retirement.”  Dorothy has served on numerous boards in higher education, research, K-12, and other types of nonprofits. She also has served on corporate boards in the financial service industry. Dorothy is currently a board member of Swarthmore College in Pennsylvania and of Oak Spring Garden Foundation in Virginia.

Dorothy’s daughter, a San Francisco artist, was diagnosed with cavernous malformation as a young adult, which led to Dorothy’s enthusiastic involvement with the Alliance to Cure Cavernous Malformation.

Kenneth Brevoort – Treasurer

Ken is an economist with 25 years of experience working on financial issues. He is a Principal Economist at the Federal Reserve Board in Washington, DC., where his work focuses on credit access, credit risk, and related banking issues. Previously, he held positions at the Consumer Financial Protection Bureau and the Office of Homeownership Preservation in the U.S. Treasury Department. Ken has maintained an active research agenda throughout his career, authoring over 30 research papers and peer-reviewed journal articles. He received his Ph.D. in Economics from The Ohio State University. Ken’s involvement with the Alliance to Cure Cavernous Malformation began in 2020 when a family member was diagnosed with CCM1. He is deeply committed to helping find treatments and, ultimately, a cure for cavernous malformations.

john andres

John is an attorney with over thirty years of experience in the medical device industry. He is a private consultant, specializing in patent/business strategy development and execution. He also is a partner of Hawk Healthcare, LLC, which provides strategic transaction management to private individuals and companies. John is a member of the Board of Directors of Longeviti Neuro Solutions, LLC, which develops and sells implant products for cranial reconstruction. In the non-profit sector, John was a member of the Executive Board of the Connecticut Yankee Council of the Boy Scouts of America from 2000 until 2012 and of The Spirit of Adventure Council from 2021-2024.

In June 2020, John was diagnosed with numerous CCM malformations throughout his brain, including one on his brainstem that bled and caused symptoms. The symptoms receded after several months and John lived with CCM for the next four years. In January 2024, while traveling back from California, John noticed that he was losing function in his legs. Upon landing in Boston, he went to Massachusetts General Hospital, where it was determined he had suffered a CCM bleed in his spine. In the brief period of 2 days, John lost all use of his legs and became paraplegic. John’s CCM is familial. His uncle had CCM and his brother also has CCM.

Karen Buck

Karen has served on the Alliance to Cure Cavernous Malformation Board of Directors as Treasurer since 2007. She retired from the New York Times after a long career in accounting and Information Technology. Karen lost her 53-year-old husband Mitch in 2010 to a rare cancer that developed at the site of his previous brain surgery for cavernous malformations. Karen’s daughter and grandson have also been diagnosed with multiple cavernous malformations. Her family is affected by a mutation of the CCM3 gene.

Christina Campos

Christina Campos has served as the administrator of Guadalupe County Hospital, a 10-bed PPS hospital in rural Santa Rosa, New Mexico, for over 19 years. Under her leadership, her hospital was recognized as a Top 20 Community Hospital by the National Rural Health Association in 2019, 2020, and 2021.

She currently serves on the boards of the New Mexico Hospital Association, the NM Hospital Services Corporation, the NM Hospital Equipment Loan Council, the NM Rural Hospital Network, and the NM Mutual Workers Compensation Casualty Company. She previously served as a former American Hospital Association Board Trustee, a former member of the HHS National Advisory Committee for Rural Health and Human Services, and Chairman of the New Mexico COVID Economic Relief Council. She is the President of her community’s local economic development corporation and Main Street Organization.

She is married to Joseph Campos, and together they have three adult children and two grandchildren. Joe and two of their daughters are affected by the Common Hispanic Mutation. Christina and her husband also own and operate a family restaurant, Joseph’s Bar & Grill, in Santa Rosa.

Tyler Fairbank

Tyler is the CEO of The Fairbank Group, LLC, the entity that manages Jiminy Peak Mountain Resort, LLC (Hancock, MA), Cranmore Mountain Resort, LLC (North Conway, N), Ski Bromley, LLC (Peru, Vermont), EOS Ventures, LLC (Hancock, MA), Bullwheel Productions, LLC, SnowGun Technologies and various other endeavors. In addition, Tyler serves as the President of Jiminy Peak, overseeing day-to-day operations. Tyler was diagnosed with a brainstem cavernous malformation which was successfully removed. He is excited to bring his business and non-profit experience to the work of Alliance to Cure Cavernous Malformation. His recovery story is briefly told in the video Road to Recovery. Tyler has also been hosting an annual fundraiser in northwest Massachusetts.

Kimberly Foley, MD

Dr. Foley is a Critical Care, Internal Medicine, and Pulmonary Disease specialist who practices in Bermuda and Brooklyn, NY. She has served on the Alliance to Cure Cavernous Malformation Board of Directors since 2019, joining soon after her diagnosis. Dr. Foley has a mutation of the CCM1 gene. Her young daughter has since been tested and has the mutation. Dr. Foley has been advising on clinical and DEI matters.

Sara Sukalich, MD MEd

Sara is serving on the board for the second time, having served as board chair from 2010-2013. She is amazed at the growth and impact of the Alliance on patients, families, researchers, and the medical community over the past two decades. Sara was diagnosed with cavernous malformations in 1994, a few months after graduating from college. Subsequently, family members in three generations have been diagnosed with the CCM1 mutation.

Sara is an OB/GYN with over twenty years of experience in medical education administration. Her career has been dedicated to physician education. She believes that training physicians to be competent, compassionate providers is the best way to make a positive impact on patients and their families. She graduated from Harvard College and obtained an MD and Master of Medical Education from the University of Cincinnati. She is also a certified health and well-being coach. She lives in Columbus, Ohio with her husband, son, and a clowder of cats.

Kandance Weems Norris

Kandance has been involved with the Alliance to Cure Cavernous Malformation since 2006 when she attended her first family conference after experiencing a cavernous malformation hemorrhage and related seizures. Her lesion is considered inoperable. This is Kandance’s second stint on our Board, previously serving from 2010 to 2013. Kandance is an attorney and has been a business law professor and executive recruiter. She graduated from Spelman College, Harvard Law, and Harvard Business School. Kandance assists the Alliance to Cure Cavernous Malformation with legal matters and medical school outreach. She lives in Durham, NC.

joseph zabramski, MD

Joseph Zabramski, MD, is an emeritus neurosurgeon and research investigator in the Barrow Aneurysm and AVM Research Center at Barrow Neurological Institute. He is also co-director of the Barrow’s CCM Center of Excellence. As an Alliance to Cure Board member, Dr. Zabramski serves as a medical advisor.

In 1994, Dr. Zabramski created a grading system for cavernous malformations which has come to be called the Zabramski classification. The system characterizes lesions as Types I through IV based on MRI characteristics. Zabramski criteria are widely used in research and have also been validated clinically as a useful tool for surgical decision-making.